Omair Khan is a Partner at ARTIS Ventures, where he focuses on early-stage investments in tech, bio, and health. He serves on multiple boards across the firm’s portfolio and closely partners with founders throughout the life cycle of their companies. Drawing on physician-scientist training and multidisciplinary experience, Omair has worked across clinical medicine, biomedical research, industry, global health, and government with interests in immunology, oncology, endometriosis, and fertility.

Omair is a recipient of the Paul & Daisy Soros Fellowship for New Americans. He completed his BS in Molecular, Cellular, and Developmental Biology and Global Health Studies at Yale University, where he was awarded the Edgar J. Poell Prize for most outstanding thesis.

‍

Investments & Boards

Onto Health, All in Bio, OverT, and Slope

‍

Incubated

Onto Health